Beneficial effects described at World Congress on Heart Failure for enrasentan in SHRSP-HSHF model July 21, 2000
Role of vasopressin and vasopressin antagonists in heart failure reviewed at recent congress July 20, 2000
CETP inhibitor JTT-705 favorably affects lipid profiles, prevents progression of atherosclerosis July 17, 2000